Breakthrough trial aims to slow devastating brain disease

NCT ID NCT07446894

Summary

This study is testing whether a supplement called MSA-01 can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder that currently has no treatment to stop it. About 140 people with MSA will take either MSA-01 or a placebo pill daily for one year. Researchers will measure whether the treatment helps patients maintain their movement abilities longer compared to those taking the placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY (MSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chiba University Hospital

    NOT_YET_RECRUITING

    Chiba, Chiba, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hokkaido University Hospital

    NOT_YET_RECRUITING

    Sapporo, Hokkaido, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institute of Science Tokyo Hospital

    NOT_YET_RECRUITING

    Bunkyō-Ku, Tokyo, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kagoshima University Hospital

    NOT_YET_RECRUITING

    Kagoshima, Kagoshima-ken, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kyoto University Hospital

    NOT_YET_RECRUITING

    Kyoto, Kyoto, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kyushu University Hospital

    NOT_YET_RECRUITING

    Fukuoka, Fukuoka, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NHO Higashisaitama National Hospital

    NOT_YET_RECRUITING

    Hasuda, Saitama, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Nagoya University Hospital

    NOT_YET_RECRUITING

    Nagoya, Aichi-ken, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Center Hospital, National Center of Neurology and Psychiatry

    NOT_YET_RECRUITING

    Kodaira, Tokyo, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Okayama University Hospital

    NOT_YET_RECRUITING

    Okayama, Okayama-ken, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The University of Tokyo Hospital

    RECRUITING

    Bunkyō-Ku, Tokyo, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tottori University Hospital

    NOT_YET_RECRUITING

    Yonago, Tottori, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.